Completed OBSERVATIONAL NCT03723304

The Intention-to-treat Effect of Bridge Therapies in the Setting of Milan-in Patients

The Intention-to-treat Effect of Bridging Therapies in the Setting of Milan-in Patients Waiting for Liver Transplantation

Sponsor: European Hepatocellular Cancer Liver Transplant Group

Conditions Liver Cancer Transplant; Failure, Liver

Interventions Bridging followed by transplant Direct liver transplant

Updated 4 times since 2018 Last updated: Oct 26, 2018 Started: Mar 1, 2018 Primary completion: Oct 15, 2018 Completion: Oct 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Liver Cancer and Transplant; Failure, Liver, this trial is completed. The trial is conducted by European Hepatocellular Cancer Liver Transplant Group and has accumulated 4 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Nov 2018 — Jan 2021 [monthly]

Completed

First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Hepatocellular Cancer Liver Transplant Group

Data source: European Hepatocellular Cancer Liver Transplant Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium